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Abstract
Background: In Sweden, organized screening programs have significantly reduced the incidence of cervical cancer.
For cancers overall, however, women with psychiatric diagnoses have lower survival rates than other women. This
study explores whether women with psychiatric diagnoses participate in cervical cancer screening programs to a
lesser extent than women on average, and whether there are disparities between psychiatric diagnostic groups
based on grades of severity.
Methods: Between 2000 and 2010, 65,292 women within screening ages of 23–60 had at least two ICD-10
(International Statistical Classification of Diseases and Related Health Problems – Tenth Revision) codes F20*–F40*
registered at visits in primary care or psychiatric care in Region Västra Götaland, Sweden. Participation in the
cervical cancer screening program during 2010–2014 was compared with the general female population using
logistic regression adjusted for age.
Results: Relative risk for participation (RR) for women diagnosed within psychiatric specialist care RR was 0.94
compared with the general population, adjusted for age. RR for diagnoses outside specialist care was 0.99. RR for
psychoses (F20*) was 0.81.
Conclusions: Women with less-severe psychiatric diagnoses participate in the screening program to the same
extent as women overall. Women who have received psychiatric specialist care participate to a lesser extent than
women overall. The lowest participation rates were found among women diagnosed with psychoses.
Keywords: Cervical cancer screening participation, Pap test, Mental illness, Psychiatric diagnoses, Equity in health
Background
TheWorld Health Organization [1] identifies cervical can-
cer as one of the most serious threats to women’s lives,
particularly in low- to middle-income countries. Screening
programs offering early detection of precancerous lesions
have helped cervical cancer incidence and mortality to de-
cline in developed countries [2]. Sweden has a relatively
long history of cervical cancer prevention, having imple-
mented organized screening programs in the mid-1960s
[3]. These efforts have significantly reduced the incidence
of cervical cancer [4, 5], and the mortality rate has de-
clined by 60% over the last four decades [6].
In Sweden, the standard practice until 2017 has been
to invite women between 23 and 60 years of age to take
a Papanicolau (Pap) test. The invitation is sent out every
three to five years depending on age [7]. In the local
context of Region Västra Götaland, over 85% of the
women accept the invitation and take a Pap test at a
local antenatal clinic [8]. Despite the relative success on
an aggregated level, the Swedish cervical cancer screen-
ing programs have proven to target segments of the
population unequally [9]. Foreign-born women attend to
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a lower degree than Swedish-born women [10, 11]. It is
also suggested that the cervical cancer screening pro-
grams fail to attract women living in rural areas [12],
women who have sex with women [13], and single
women [14]. Moreover, participation rates are lower in
socioeconomically disadvantaged areas, suffering from
poor educational and income levels as well as high un-
employment rates [15, 16]. However, Swedish studies ex-
ploring whether mental illness constitute a barrier to
attend cervical cancer screening programs are sparse.
Mental illness is suggested to have increased among
the Swedish population since the early 1990s, particu-
larly among women between 16 and 34 years of age [17].
Persons with psychiatric diagnoses often have poorer
somatic health status and lower life expectancy than the
general population [18]. There are also disparities in
Swedish cancer care, in which patients with psychiatric
diagnoses die from their cancer to a greater extent than
other patients [19]. Women with psychiatric diagnoses
received their breast cancer diagnosis and treatment at a
later stage than other patients with breast cancer, indi-
cating that mentally ill women are not screened to the
same extent as other women [19].
International studies have investigated the correlation
between psychiatric diagnoses and cervical cancer screen-
ing participation. In Canadian [20] and Taiwanese [21]
studies, women diagnosed with schizophrenia proved less
likely to have a Pap test than women without such a diag-
nosis. Another Canadian study [22] found that women
with psychosis were five times less likely to have a Pap test
than women without psychosis. On the contrary, within a
group of US women with depression, it could not be
found that women with high depressive symptom burden
in the subsequent year had lower odds for Pap testing
[23]. Naturally, there are variations among the group of
mentally ill women. In another Canadian study [24], youn-
ger depressed women were found to be more likely to
have had a recent Pap test than older depressed women.
Despite the relatively positive results of Swedish cervical
cancer prevention, approximately 140 women still die from
the disease annually [25], three-quarters of whom had not
taken a Pap test within the recommended intervals [26].
Thus, identifying nonparticipants is crucial in order to
launch interventions for the relevant group. The present
paper addresses the following questions: Compared with in-
vited women overall, to what extent do women with psychi-
atric diagnoses attend the cervical cancer screening
program? Are there differences in participation rates across
psychiatric diagnostic groups and grades of severity?
Methods
Study design
Despite varieties within the decentralized Swedish health-
care system, the organization of psychiatric care is largely
similar across the various regions/councils. As stated in
regional guidelines [27], primary care is responsible for
early detection and assessment of psychiatric states among
the patients seeking care. This level of care is responsible
for treating patients with generalized anxiety disorder,
panic syndrome, crisis reaction, obsessive compulsive dis-
order, social phobia, mild to moderate forms of depres-
sion, post-traumatic stress syndrome, self-harm, substance
abuse, and eating disorders. Besides physicians and nurses,
psychologists and psychotherapists work at the primary
care centers. Specialist psychiatry is responsible for treat-
ing patients who suffer from attention deficit hyperactivity
disorder and autism, schizophrenia and other psychoses,
bipolar syndrome, relapsing depressions, and severe forms
of depression, posttraumatic stress syndrome, self-harm,
substance abuse, and eating disorders.
Data was retrieved from three registers. The first is the
Vega database, the comprehensive database for health-
care consumption in the Region Västra Götaland. This
database includes person-bound diagnosis in all health-
care, in-patient and out-patient, specialized care and pri-
mary care. This publicly owned database was established
in 2000 and weekly deliveries of data are compulsory
from all sectors of healthcare in the region [28]. The sec-
ond register is the process quality register for cervical
screening. This is part of the national quality register for
cervical screening [29] and has had 100% coverage since
1993 for cervical smears in the Region Västra Götaland,
taken as screening or clinical sample, and in public- and
private-run facilities. The third register is the Swedish
total population register from the government-run Sta-
tistics Sweden [30]. Data was linked by the 12-digit per-
sonal number assigned to all citizens in Sweden.
Cohort definition
As a reference cohort, we used all women registered as
residents in the geographical region of Västra Götaland on
December 31, 2014 who were aged between 23 and 60. In
total, 341,171 women were included in this cohort.
Inclusion criteria for the study cohort included women
registered as residents in the region of Västra Götaland
on December 312,014; were aged between 23 and 60;
who had visited psychiatric outpatient clinics and/or pri-
mary care between 2000 and 2010 and, on at least two
of these occasions were diagnosed with any of the fol-
lowing diagnosis and ICD-10 (International Statistical
Classification of Diseases and Related Health Problems
– Tenth Revision) codes: psychoses (F20*–29*); affective
disorders (F30*–39*); or phobia, anxiety, stress, etc.
(F40*–48*). A woman did not need to have the same
diagnosis on both occasions in order to be included in
the study cohort. In the Vega database of Region Västra
Götaland, at total of 65,292 women were identified in ac-
cordance with the above.
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Each woman in the study cohort was sorted into a diag-
nostic group, based on her most severe diagnosis. Conse-
quently, diagnoses within F30 and F40 were graded either
S (severe, contact with psychiatric specialist) or L (less se-
vere, no contact with psychiatric specialist). No grading
was made of F20, as all women with diagnosis of psychosis
had contact with psychiatric specialist. Thus, the diagno-
ses, ranked from most to least severe, were: (1) F20, (2)
F30S, (3) F40S, (4) F30 L, and (5) F40 L.
Outcome
Participation in the cervical cancer screening program
from January 1, 2010 to June 30, 2015 for the study cohort
were compared with reference cohort’s participation dur-
ing the same period of time. Because of the standard prac-
tice in which women under 50 years of age are invited to
the screening program every three years, and women over
50 years of age are invited every five years, all invited
women should have received at least one invitation during
the selected period of time. Due to invitation procedures
that allow some variance, a five-and-a-half-year outcome
period was set.
Statistical analysis
The analysis was conducted using logistic regression ad-
justed for age and censored for outcome before expos-
ure. The latter was relevant due to an overlap in the
intervals of 2010, meaning there was a risk that women
in the study cohort could have participated in the
screening program before being exposed for psychiatric
diagnoses. Consequently, “censored for outcome before
exposure” indicates that “participation” in the screening
program for women in the study cohort is relevant only
if they had participated after two registered psychiatric
diagnoses. However, there were no censored patients in
this study. The relative risk (RR) and 95% confidence
interval (CI) were calculated. All statistical analysis were
performed using R.
Results
Table 1 describes the baseline characteristics of our
study cohort by age and most severe psychiatric
diagnosis.
The first row in Table 2 shows the number of visits
with one or several psychiatric diagnoses for the study
cohort on an annual level. Because the patients may re-
visit healthcare providers year after year and the cohort
gradually increases, these numbers appear to have a cu-
mulative nature. The second row show the number of
unique patients calculated on the basis of the first visit
with psychiatric diagnosis during the study period.
As shown in Table 3, the relative risk for participation
(RR) among women within the group that had contact
with specialist psychiatric care (FxxS) was 0.94 (p < 0.05).
The RR for diagnoses without contact with psychiatric
specialist care was 0.99 (p < 0.05). The RR for women with
psychotic diagnoses (F20*–F29*) was 0.81 (p < 0.05).
Discussion
Despite the effectiveness in reducing cancer mortality [31,
32], participation rates among groups of women in cer-
vical cancer screening programs vary [33]. This study adds
to previous knowledge of participation in cervical cancer
screening among women with psychiatric diagnoses by
highlighting the potential difference in participation
among women with severe and less severe such diagnoses.
The strengths of the study include a population-based co-
hort design with a large sample size. Using high-quality
registers instead of self-reported exposure and outcome
information further adds to its strengths.
This study could not report any considerable differences
in risk of participation in the local screening program be-
tween the general reference group and the study group
with psychiatric illness overall. Due to the large size of the
study, almost all differences are statistically significant, but
the clinical importance of the difference is small. Similarly,
previous research [23] has not found that the odds of tak-
ing a Pap test are lower for women with high depressive
symptom burden. However, within the study cohort there
were important variations in this study. For example,
women who attended psychiatric specialist care were less
likely to participate in the screening program than women
who had received their psychiatric diagnoses in primary
care or elsewhere; this most probably reflects differences
in the severity of the disease. Most notably, and similar to
previous findings [20–22], women with psychosis and ob-
sessive/compulsive disorders in specialist care were least
likely to have a Pap test, while women with even severe
Table 1 Baseline characteristics of the study cohort
Baseline characteristics No. of Women
Age (years)
23–30 11,288
31–40 19,335
41–50 24,176
51–60 10,493
Diagnosis
Psychosis F20*–29* 2364
Affective disorder F30*–39*, specialist care 15,858
Phobia, anxiety, stress, etc. F40*–48*, specialist care 122
Affective disorder F30*–39*, not specialist care 27,974
Phobia, anxiety, stress, etc. F40*–48*, not
specialist care
18,974
Total 65,292
*All subgroups included
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affective disorders participated in screening to the same
extent as the general population.
We constructed a hierarchy of groups of psychiatric
diagnoses, which served as the base for selecting the most
severe diagnosis when women had more than one. This
scale is not validated. Another limitation is that the com-
pleteness of the large Vega database is not validated, which
means that data from its development phase – the first
years after 2000 – could be missing. This bias could theor-
etically underestimate the true difference. However, this
bias seems to be very limited, given that the largest num-
ber of unique patient entries was registered in 2001, the
second year after the start of the database (Table 3).
We have not had access to other data that could have
an association with the outcome, such as socioeconomic
deprivation and marital status. Adjusting for such factors
could be of further epidemiologic interest, although it is
beyond the scope of this study as we aim to study actual
participation in the screening program and identify dif-
ferences across psychiatric diagnosis, not to investigate
causality.
The strengths of this study are that it covers the entire
population and that outcome data comes from a compre-
hensive database with total coverage of the population.
The criterion that women had to have been diagnosed on
at least two occasions in order to be included in the study
cohort also provides a validation of psychiatric illness.
Official national reports [19] and previous inter-
national studies [34] report higher cancer mortality rates
in people with psychiatric diagnoses compared to the
population overall. Concerning cervical cancer, some re-
search [35] has not found any differences in the risk of
developing cervical cancer between patients with schizo-
phrenia and patients without the diagnosis. Indeed, a
Danish study [36] suggested that patients with schizo-
phrenia had a decreased risk of developing cervical can-
cer compared to other women. Our study indicates that
women with psychosis have a 20% lower screening par-
ticipation than the general population, and thus a lower
protection against cervical cancer. If this finding was
also valid for breast cancer screening, it could explain
part of the pronounced worsened stage-distribution
found for patients with psychosis [19].
For women with schizophrenia, it is suggested that good
continuity of care increases the likelihood of a Pap test be-
ing taken [20]. A general barrier for participation in cer-
vical screening programs is suggested to be its impersonal
and anonymous nature [37]. To overcome this, it is con-
sidered important not only to focus on printed material
and invitations, but also to spread information orally [38]
or by films [39], to include women’s social networks in
dissemination of information [10, 40, 41], or to arrange
special events [42]. Representatives of non-participants
may also be invited to identify barriers, propose solutions,
and to execute these solutions to their peers [15, 16]. In
the local context of this study, the healthcare provider’s
suggested actions to overcome inequities include annual
counseling for persons with psychiatric illnesses about
somatic status, including whether they had participated in
mammography and had a Pap test taken [43].
Table 2 Number of visits with psychiatric disease diagnoses and number of unique new patients in the study by year
Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
No. of visits 5300 19,991 37,816 55,258 64,940 69,757 89,995 103,786 108,276 152,644 185,008
Patient’s first time diagnosed 2749 7702 7235 7221 7530 6172 6080 5125 4702 5496 5280
Table 3 Participation rates and the relative risks (RR) for participation by group of psychiatric ICD diagnosis and severity as level of
care. (S) = Specialist care, (L) = Non-specialist care. Adjustment made for age
Group Raw Rate Adjusted Rate Adjusted Rate L Adjusted Rate U Adjusted RR Adjusted RRL Adjusted RRU
Reference cohort 88.5 88.5 1.00
Study cohort 86.0 86.4 86.1 86.7 0.98 0.97 0.98
FxxS (all severe) 82.6 83.1 82.6 83.7 0.94 0.93 0.95
FxxL (all less severe 87.3 87.7 87.4 88.0 0.99 0.99 1.00
F20*–F29* (all) 69.8 71.2 69.4 73.0 0.81 0.78 0.83
F30*–F39* (all) 85.9 86.4 86.0 86.7 0.98 0.97 0.98
F40*–F48* (all) 88.1 88.5 88.0 89.0 1.00 1.00 1.01
F30*–F39* (S) 84.5 85.0 84.4 85.5 0.96 0.95 0.97
F30*–F39* (L) 86.7 87.1 86.7 87.5 0.98 0.98 0.99
F40*–F48* (S) 76.2 76.3 68.2 83.3 0.86 0.77 0.94
F40*–F48* (L) 88.2 88.5 88.1 89.0 1.00 1.00 1.01
*All subgroups included
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Moreover, it is suggested that participation of persons
with serious mental illnesses may vary between different
programs, with higher participation in cervical cancer
screening than breast, prostate, and colorectal cancers
[44]. This suggests that non-participation may be even
greater in other screening programs than the cervical
cancer screening program of this particular study.
In the local context of Region Västra Götaland in
Sweden, the last two decades have seen great efforts to
methodically improve knowledge of cervical cancer and
increase participation in the local screening program.
Consequently, overall participation in the regional cer-
vical cancer screening program is higher than in many
other regions in Sweden [29]. These efforts may have
benefitted women with psychiatric diagnoses as well, es-
pecially explaining the almost identical participation be-
tween women with less severe (L) psychiatric diagnoses
and women overall in this study.
Conclusions
Most women in Sweden participate in the cervical
screening program. This study has found that women
with less severe psychiatric diagnoses participate in the
screening program to a similar extent as women overall.
While women with severe affective disorders also have a
high participation rate, women with other psychiatric
diagnoses requiring specialist care, such as psychosis,
participate less. This implies that psychiatric specialist
care should better support their female patients to par-
ticipate in the cervical screening programs, and other ac-
tors in the healthcare system should better support
engagement for the group in the screening program.
Endnote
*All subgroups included.
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